Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
Cingulate Inc., a biopharmaceutical company focused on innovative drug delivery technology for ADHD and anxiety, has been added to the Russell 3000E® Index. This inclusion is expected to increase institutional investor awareness and support long-term growth. Their lead product candidate, CTx-1301, uses a proprietary Precision Timed Release™ platfor…